Literature DB >> 34467976

Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress.

Nathalie Sumien1, J Thomas Cunningham2, Delaney L Davis1, Rachel Engelland3, Oluwadarasimi Fadeyibi3, George E Farmer2, Steve Mabry3, Paapa Mensah-Kane1, Oanh T P Trinh1, Philip H Vann1, E Nicole Wilson3, Rebecca L Cunningham3.   

Abstract

Neurodegenerative diseases cause severe impairments in cognitive and motor function. With an increasing aging population and the onset of these diseases between 50 and 70 years, the consequences are bound to be devastating. While age and longevity are the main risk factors for neurodegenerative diseases, sex is also an important risk factor. The characteristic of sex is multifaceted, encompassing sex chromosome complement, sex hormones (estrogens and androgens), and sex hormone receptors. Sex hormone receptors can induce various signaling cascades, ranging from genomic transcription to intracellular signaling pathways that are dependent on the health of the cell. Oxidative stress, associated with aging, can impact the health of the cell. Sex hormones can be neuroprotective under low oxidative stress conditions but not in high oxidative stress conditions. An understudied sex hormone receptor that can induce activation of oxidative stress signaling is the membrane androgen receptor (mAR). mAR can mediate nicotinamide adenine dinucleotide-phosphate (NADPH) oxidase (NOX)-generated oxidative stress that is associated with several neurodegenerative diseases, such as Alzheimer disease. Further complicating this is that aging can alter sex hormone signaling. Prior to menopause, women experience more estrogens than androgens. During menopause, this sex hormone profile switches in women due to the dramatic ovarian loss of 17β-estradiol with maintained ovarian androgen (testosterone, androstenedione) production. Indeed, aging men have higher estrogens than aging women due to aromatization of androgens to estrogens. Therefore, higher activation of mAR-NOX signaling could occur in menopausal women compared with aged men, mediating the observed sex differences. Understanding of these signaling cascades could provide therapeutic targets for neurodegenerative diseases.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AR45; angiotensin; estrogen; membrane androgen receptor; oxidative stress; testosterone

Mesh:

Substances:

Year:  2021        PMID: 34467976      PMCID: PMC8462383          DOI: 10.1210/endocr/bqab185

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   5.051


  194 in total

Review 1.  Sex chromosome aneuploidy and aging.

Authors:  J F Stone; A A Sandberg
Journal:  Mutat Res       Date:  1995-10       Impact factor: 2.433

Review 2.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

Review 3.  Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders.

Authors:  Mohammad Fahad Ullah; Aamir Ahmad; Showket Hussain Bhat; Faisel M Abu-Duhier; George E Barreto; Ghulam Md Ashraf
Journal:  Neurosci Biobehav Rev       Date:  2019-04-05       Impact factor: 8.989

Review 4.  Statin inhibition of HMG-CoA reductase: a 3-dimensional view.

Authors:  Eva Istvan
Journal:  Atheroscler Suppl       Date:  2003-03       Impact factor: 3.235

5.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Authors:  Peter P Zandi; D Larry Sparks; Ara S Khachaturian; Joann Tschanz; Maria Norton; Martin Steinberg; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Gen Psychiatry       Date:  2005-02

Review 6.  Prenatal and postnatal hormone effects on the human brain and cognition.

Authors:  Bonnie Auyeung; Michael V Lombardo; Simon Baron-Cohen
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

7.  Sex differences in Alzheimer's disease and common neuropathologies of aging.

Authors:  Shahram Oveisgharan; Zoe Arvanitakis; Lei Yu; Jose Farfel; Julie A Schneider; David A Bennett
Journal:  Acta Neuropathol       Date:  2018-10-17       Impact factor: 17.088

Review 8.  Sex differences in movement disorders.

Authors:  Sara Meoni; Antonella Macerollo; Elena Moro
Journal:  Nat Rev Neurol       Date:  2020-01-03       Impact factor: 42.937

Review 9.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

Review 10.  Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.

Authors:  Anju Singh; Ritushree Kukreti; Luciano Saso; Shrikant Kukreti
Journal:  Molecules       Date:  2019-04-22       Impact factor: 4.411

View more
  3 in total

1.  Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.

Authors:  Youngkwon Jo; Seungyeon Kim; Byoung Seok Ye; Euni Lee; Yun Mi Yu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

2.  A Healthful Plant-Based Diet Is Associated with Lower Odds of Nonalcoholic Fatty Liver Disease.

Authors:  Xiude Li; Zhaohong Peng; Meiling Li; Xueke Zeng; Haowei Li; Yu Zhu; Hui Chen; Anla Hu; Qihong Zhao; Zhuang Zhang; Hua Wang; Changzheng Yuan; Wanshui Yang
Journal:  Nutrients       Date:  2022-10-02       Impact factor: 6.706

3.  Inhibition of the integrated stress response reverses oxidative stress damage-induced postoperative cognitive dysfunction.

Authors:  Linhao Jiang; Rui Dong; Minhui Xu; Yujia Liu; Jiyan Xu; Zhengliang Ma; Tianjiao Xia; Xiaoping Gu
Journal:  Front Cell Neurosci       Date:  2022-09-21       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.